| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |